Dermatology · Johnson City, TN
NPI
1013902907
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2898 Boones Creek Rd Ste 105
Johnson City, TN, 37615
Phone (423) 262-0112
Groups this clinician bills Medicare through
Medicare paid, 2024
$547K
7,543 services
Medicare patients, 2024
595
Average age 76
Drug cost, 2024
$888K
2,125 prescriptions
Company payments, 2025
$323
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stuart S Leicht was code 17003 (destruction skin lesion), 1,055 times for 164 patients. In total Stuart S Leicht billed 7,543 services in 88 codes, and Medicare paid $547K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,055 | 164 | $4.31 | $4,551 |
| 99213 Office E&M - Established | Office | 1,032 | 488 | $58.71 | $61K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 992 | 46 | $127.25 | $126K |
| 77280 Radiation Treatment Planning | Office | 960 | 44 | $189.20 | $182K |
| 77401 Conventional Radiation Treatment | Office | 924 | 44 | $29.13 | $27K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 441 | 54 | $0.66 | $292 |
| 17000 Destruction Skin Lesion | Office | 329 | 212 | $37.18 | $12K |
| 99214 Office E&M - Established | Office | 302 | 224 | $84.35 | $25K |
| 99212 Office E&M - Established | Office | 173 | 42 | $41.12 | $7,114 |
| 77336 Radiation Treatment Planning | Office | 136 | 41 | $61.71 | $8,393 |
| 11102 Skin Biopsy | Office | 123 | 102 | $61.32 | $7,542 |
| 17110 Destruction Skin Lesion | Office | 104 | 87 | $65.11 | $6,771 |
| 99203 Office E&M - New | Office | 88 | 88 | $68.23 | $6,004 |
| 96372 Injection Administration | Office | 78 | 58 | $8.66 | $675 |
| 99204 Office E&M - New | Office | 64 | 64 | $93.90 | $6,010 |
By year: 2022 $201K for 3,983 services; 2023 $271K for 4,968 services; 2024 $547K for 7,543 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stuart S Leicht prescribed most often to Medicare patients was Betamethasone Dipropionate, with 340 prescriptions and refills. In total Stuart S Leicht wrote 2,125 Medicare prescriptions that cost $888K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Dipropionate Generic | 340 | 361 | 169 | $17K |
| Triamcinolone Acetonide Generic | 300 | 356 | 190 | $3,980 |
| Minocycline Hcl Generic | 173 | 251 | 51 | $5,953 |
| Doxycycline Hyclate Generic | 159 | 240 | 43 | $6,052 |
| Hydroxychloroquine Sulfate Generic | 93 | 165 | 26 | $2,942 |
| Fluocinonide Generic | 89 | 94 | 49 | $3,652 |
| Methotrexate Methotrexate Sodium | 75 | 134 | 21 | $1,321 |
| Fluorouracil Generic | 64 | 66 | 59 | $5,554 |
| Minoxidil Generic | 56 | 77 | 13 | $698 |
| Ammonium Lactate Generic | 48 | 62 | 23 | $2,220 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 39 | 42 | 19 | $1,047 |
| Valacyclovir Valacyclovir Hcl | 36 | 48 | 14 | $1,304 |
| Prednisone Generic | 35 | 37 | 14 | $253 |
| Acitretin Generic | 35 | 37 | Under 11 | $6,990 |
| Ketoconazole Generic | 34 | 37 | 22 | $639 |
Brand drugs: 141 claims; generic drugs: 1,984 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stuart S Leicht $323 ($323 in general payments such as food, travel and fees) from 5 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $178.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 10 | $178 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $49.74 |
| Janssen Biotech, Inc. JNJ | 2 | $39.64 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $34.11 |
| Lilly USA, LLC LLY | 1 | $21.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.